BiotechTube
Home/OT4B/François Vuillet
FV

François Vuillet

CEO

OT4B

Therapeutic Areas

Prader-Willi SyndromeRare Genetic DisordersNeurodevelopmental Disorders

OT4B Pipeline

DrugIndicationPhase
Oxytocin & PWS ProgramPrader-Willi Syndrome (Neonates/Infants)Phase 2

Leadership Team at OT4B

PM
Prof. Maithé Tauber
Scientific Founder / Principal Investigator (Toulouse University Hospital)
View full OT4B profile